Cerebral cavernous malformations (CCMs) are human vascular malformations caused by mutations in three genes of unknown function: KRIT1, CCM2 and PDCD10. Here we show that the heart of glass (HEG1) receptor, which in zebrafish has been linked to ccm gene function, is selectively expressed in endothelial cells. Heg1 -/-mice showed defective integrity of the heart, blood vessels and lymphatic vessels. Heg1 -/-; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ mice had more severe cardiovascular defects and died early in development owing to a failure of nascent endothelial cells to associate into patent vessels. This endothelial cell phenotype was shared by zebrafish embryos deficient in heg, krit1 or ccm2 and reproduced in CCM2-deficient human endothelial cells in vitro. Defects in the hearts of zebrafish lacking heg or ccm2, in the aortas of early mouse embryos lacking CCM2 and in the lymphatic vessels of neonatal mice lacking HEG1 were associated with abnormal endothelial cell junctions like those observed in human CCMs. Biochemical and cellular imaging analyses identified a cell-autonomous pathway in which the HEG1 receptor couples to KRIT1 at these cell junctions. This study identifies HEG1-CCM protein signaling as a crucial regulator of heart and vessel formation and integrity.
CCMs are a common vascular malformation, with a prevalence of 0.1%-0.5% in the human population 1 . CCMs arise primarily in the brain as thin-walled, dilated blood vessels that cause seizures, headaches and stroke in midlife, often in association with focal hemorrhage 1, 2 . Familial CCM shows an autosomal dominant pattern of inheritance and is caused by loss-of-function mutations in three genes: KRIT1 (also known as CCM1) 1, 3, 4 , CCM2 (also known as malcalvernin and osm) 5, 6 and PDCD10 (also known as CCM3) 7 . The CCM proteins are putative adaptor proteins that interact biochemically [8] [9] [10] and participate in a signaling pathway that is not yet fully characterized. The mechanism by which loss of CCM protein signaling results in the development of vascular malformations is not known.
A clue to the role of CCM protein signaling in the cardiovascular system comes from genetic studies in zebrafish, which reveal that loss of krit1, ccm2 or heg (encoding the type I transmembrane receptor heart of glass) results in a dilated heart phenotype early in development 11, 12 . This phenotype is characterized by heart failure associated with enlarged cardiac chambers in which the endocardium is covered by a thin layer of myocardial cells. Expression of heg, krit1 and ccm2 mRNA has been detected in the endocardium, but not the myocardium, of zebrafish embryos 11, 12 , suggesting that these proteins operate in an endothelial cell-autonomous signaling pathway. An endothelial role for this pathway is also supported by studies of KRIT1-deficient mice, which show lethal vascular defects at embryonic day 9 (E9); however, these studies did not detect high-level Krit1 or Ccm2 gene expression in the mouse cardiovascular system, leading to the proposal of cell-nonautonomous mechanisms of CCM pathogenesis such as a requirement for CCM protein signaling in adjacent neuronal cells 13, 14 .
Here we used mice and zebrafish lacking the HEG1 receptor and the CCM2 adaptor to investigate the role of this pathway in the cardiovascular system. Our studies support an endothelial cell-autonomous mechanism in which the HEG1 receptor couples to CCM proteins to regulate endothelial cell-cell junctions required for the formation and maintenance of the heart and vessels. Complete loss of function in this pathway resulted in an inability of emerging endothelial cells to associate into a functional cardiovascular system in mouse and zebrafish embryos. Less-complete loss of function permitted heart and vessel development but resulted in integrity defects manifested by cardiac rupture, vascular hemorrhage and lymphatic leakage. These cardiovascular defects arose in conjunction with abnormal endothelial © 2009 Nature America, Inc. All rights reserved.
junctions similar to those observed in human CCMs [15] [16] [17] and associated with KRIT1 depletion in human endothelial cells in vitro 18 , suggesting a common mechanism by which loss of this signaling pathway confers a spectrum of vertebrate cardiovascular defects in developing and mature animals. Our studies indicate that the signaling pathway implicated in human CCM regulates endothelial cell-cell association and suggest that agents designed to promote endothelial cell association may be effective treatments for CCM.
RESULTS

Heg1 is expressed in the developing cardiovascular system
It has been unclear how CCM proteins function in cardiovascular cell types and whether it is loss of CCM protein function in cardiovascular or other cell types that causes human vascular disease. To determine whether HEG1 receptors have a direct role in regulating CCM protein signaling, we cloned the mouse Heg1 gene (Supplementary Fig. 1 online) and characterized Heg1 mRNA expression in mice. Using in situ hybridization, we detected Heg1 expression in the endothelium of the developing heart and aorta and in the neural tube at E10.5 (Fig. 1a) , and in the arterial endothelium, smooth muscle, endocardium of the heart and brain vasculature at E14.5 ( Fig. 1b and Supplementary Fig. 2 online) . In contrast to Heg1, Ccm2 expression was low and detected primarily in the developing neural tube at E10.5 ( Supplementary Fig. 3 online) .
HEG1 deficiency results in lethal hemorrhage in mice
To address the role of the HEG1 receptor in mammals, we generated HEG1-deficient mice by targeting Heg1 exon 1 in embryonic stem cells ( Supplementary Fig. 4 online). In mice with genetic backgrounds of 50% SV129 and 50% C57Bl/6 or 495% C57Bl/6, HEG1 deficiency resulted in embryonic and postnatal lethality (Supplementary Table 1 online). Midgestation HEG1-deficient embryos showed cardiac defects characterized by invagination of the ventricular cavity into, and often through, the compact layer of ventricular myocardium ( Fig. 1c-f ). The septal myocardium was similarly honeycombed by endothelial-lined extensions from the ventricular cavity (Fig. 1d) , a defect accompanied by the presence of ventricular septal defects in most late-gestation embryos. TUNEL and Ki67 staining revealed that HEG1-deficient myocardial defects were not caused by an increase in myocardial apoptosis or a decrease in myocardial proliferation ( Supplementary Fig. 5 online and data not shown). Although most HEG1-deficient mice survived to birth, approximately half died before weaning as a result of pulmonary hemorrhage ( Fig. 1g-i) . Neonatal HEG1-deficient mice also showed defective cardiac integrity manifested by a blood-filled pericardial sac, a phenotype that arose as a result of rupture of the low-pressure atrial chamber of the heart (Fig. 1j) . Cardiac or pulmonary integrity defects were observed in 50% of HEG1-deficient mice. These findings indicate that HEG1 deficiency results in a loss of cardiac and pulmonary vascular integrity, resulting in lethality. Figure 1 Heart and blood vessel integrity defects in HEG1-deficient mouse embryos and neonates. (a,b) Heg1 was selectively expressed in the developing cardiovascular system. Radioactive in situ hybridization revealed Heg1 expression in the vascular endothelium, cardiac endocardium and neural tube at E10.5 (a). By E14.5, Heg1 was expressed in both endothelial and smooth muscle cells in major arteries (b). ao, aorta; h, heart; nt, neural tube. (c-f) E15 Heg1 -/-embryos showed deep invaginations of the ventricular chamber into the compact zone of the ventricular wall and into the septum, often associated with the presence of blood between the epicardial and myocardial cell layers of the heart (arrow in f). e,f show magnification of boxed regions in c,d. (g-i) Pulmonary hemorrhage in Heg1 -/-neonates (h,i) but not in Heg1 +/+ littermates (g) was manifested by the presence of erythrocytes and fibrin in alveolar air spaces. (j) Cardiac rupture in P4 Heg1 -/-neonate. Hemopericardium (left, middle) associated with cardiac rupture and formation of a transmural thrombus (right) was observed in Heg1 -/-mice. VSD, ventricular septal defect. Scale bars, 200 mm in a-d and j (middle), 20 mm in e-i and j (right). 
HEG1 deficiency causes dilated lymphatic vessel malformations
Neonatal mammals transport absorbed fat through the intestinal and mesenteric lymphatic vessels in the form of white chyle. A distinct phenotype observed in approximately 10% of HEG1-deficient neonatal mice was the appearance of chylous ascites shortly after their first feeding (Fig. 2a,b) . Chylous ascites was invariably associated with severely dilated intestinal and mesenteric lymphatic vessels that leaked chyle into the intestinal wall and peritoneal space (Fig. 2c-f) . The dilated mesenteric lymphatic vessels were lined with endothelial cells that expressed the lymphatic molecular marker LYVE1 and were associated with smooth muscle cells typical of collecting lymphatic vessels (Fig. 2g,h ). These findings indicate that loss of HEG1 receptors is associated with a loss of integrity of lymphatic vessels as well as of blood vessels and the heart. Because lymphatic vessels are not subject to the hemodynamic forces generated by the beating heart, these findings further suggest that loss of integrity arises as an intrinsic defect in the heart and vessels of HEG1-deficient mice.
Heg1 and Ccm2 interact genetically in mice Identical big-heart phenotypes arise in zebrafish embryos lacking heg, krit1 (also known as santa) or ccm2 (also known as valentine), and gene-knockdown experiments using morpholinos have shown strong interactions among these genes in zebrafish 12 . In contrast, human CCMs have been linked to loss-of-function mutations in KRIT1 and CCM2, but not HEG1, and HEG1-deficient mice do not experience the early embryonic lethality reported for KRIT1-deficient mice 13 . To determine whether-and to what extent-HEG1 interacts genetically with CCM genes in mammals, we intercrossed Heg1 +/-; Ccm2 lacZ/+ mice. The Ccm2 lacZ allele is predicted to be a null allele because the Ccm2 lacZ mRNA transcript lacks the 3¢ half of the Ccm2 mRNA (exons 6-10, Supplementary Fig. 6 online), and Ccm2 lacZ/lacZ embryos experience early embryonic lethality that phenocopies Krit1 À/À embryos (see below and ref. 13) . In contrast to Heg1 -/-; Ccm2 +/+ mice, which showed no abnormalities before midgestation, both Heg1 -/-; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ embryos died before E10 (Supplementary Table 2 online). Heg1 -/-; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ embryos were indistinguishable from littermates of all other genotypes until E9, when the mutants showed identical phenotypes of growth retardation and marked pericardial edema despite the presence of a visibly normal heartbeat (data not shown). Histologic examination revealed normal development of the ventricular chamber and bulbus cordis (future right ventricle) but aberrant formation of a dilated aortic sac ( Fig. 3 and Supplementary Fig. 7 lacked luminal blood cells ( Fig. 3 and Supplementary Fig. 7 ). Analysis of serial transverse sections revealed that the aortic sac did not connect to a lumenized first, second or third branchial arch artery in the mutant embryos, suggesting that blood in the heart did not enter the dorsal aortas despite the presence of a normal heartbeat ( Fig. 3 and Supplementary Fig. 7 ). When visible, the cardinal veins of E9 Heg1 -/-; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ embryos were also devoid of blood, except at the point where they connected to the sinus venosus of the heart (Fig. 3) . In contrast to the lack of blood in the vessels, extravasated blood cells were frequently present in the dilated pericardial cavity ( Fig. 3 and data not shown), a finding that may reflect a primary defect in the integrity of the heart; alternatively, this finding may arise from the heart beating against a closed circulatory system and/or from reduced embryonic viability at this point in development.
To determine whether the lack of blood-filled vessels in E9 Heg1 -/-; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ embryos is due to a lack of endothelial cells, we used Flk1 immunostaining to identify endothelial cells. We found endothelial cells at sites where the branchial arch arteries and dorsal aortas are normally located, but in all Heg1 -/-; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ embryos studied these cells were not organized into lumenized vessels as they were in control embryos (Fig. 3) . Thus, circulation in Heg1 -/-; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ embryos was blocked by an inability of mutant endothelial cells to form lumenized vessels capable of carrying blood. These findings indicate a strong genetic interaction between HEG1 receptors and the CCM protein signaling pathway during formation of the primary vasculature in mammals.
heg and ccm2 are required for vessel patency in zebrafish In contrast to E9 Heg1 -/-; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ mouse embryos, zebrafish embryos lacking heg or ccm2 show primarily cardiac defects 11, 12 . To determine whether HEG1 and CCM proteins have differing roles in cardiovascular development in zebrafish and mice, we examined vascular patterning and function in heg-morphant, ccm2-morphant and ccm2-mutant zebrafish embryos at 48 hours post fertilization (h.p.f.). Morpholino knockdown of heg or ccm2 in Fli1-GFP transgenic fish (which have GFP-labeled endothelium) resulted in dilated heart chambers but no abnormalities in vessel patterning (Fig. 4a) . However, we noted visually that blood cells in the hearts of heg-and ccm2-morphant zebrafish did not circulate despite detectable contraction of the dilated heart, a finding similar to the circulatory block we observed in E9 Heg1 -/-; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ mouse embryos.
We used angiography to functionally test the patency of the vasculature of heg-and ccm2-morphant zebrafish. Fluorescent beads injected into the sinus venosus of zebrafish embryos treated with control morpholinos circulated throughout the body and outlined the developing vasculature of the head and tail (Fig. 4b) . In contrast, injection of heg-or ccm2-morphant zebrafish revealed a complete or near-complete circulatory block immediately distal to the heart (Fig. 4b) , the same point at which circulation was blocked in E9 Heg1 -/-; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ mouse embryos. We also observed a complete circulatory block in all ccm2-mutant zebrafish embryos injected with FITC-dextran (Fig. 4c) . These findings indicate a conserved role for HEG1 and CCM2 in the formation of a patent vertebrate circulatory system.
HEG1-CCM signaling regulates endothelial tube formation
The inability of nascent endothelial cells to form patent branchial arch vessels in Heg1 -/-; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ mouse embryos and heg-or ccm2-morphant zebrafish embryos suggested that HEG1-CCM protein signaling is required for endothelial cells to form lumenized tubes during early vascular development. To assess the role of CCM2 in endothelial tube formation, we used a fibrin bead assay to examine the ability of human umbilical vein endothelial cells (HUVECs) expressing CCM2-specific or scrambled control small hairpin RNAs to form tubes 19 . CCM2-specific small hairpin RNA resulted in an 85%-90% reduction in CCM2 mRNA expression and had no effect on endothelial cell size, proliferation or migration ( Supplementary Fig. 7 and data not shown). Although control HUVECs generated multicellular structures with clearly visible mature lumens at 10 d, CCM2-deficient HUVECs formed branched cords similar to those of control cells in length but were frequently unable to form visible lumens ( Supplementary Fig. 7 ).
© 2009 Nature America, Inc. All rights reserved. 8 Studies of lumen formation by endothelial cells in vitro and in the intersegmental vessels (ISVs) of the zebrafish embryo in vivo have shown that endothelial cells can assemble lumenized vessels through the formation and fusion of intracellular vacuoles [20] [21] [22] [23] . We assessed the formation of vacuole-like structures in the ISVs of morphant and control zebrafish embryos using transgenic zebrafish expressing GFP-Cdc42 fusion proteins that outline the intracellular vacuoles that form in endothelial cells 22 . Endothelial vacuole-like structures formed normally in the ISVs of zebrafish embryos lacking heg or ccm2 ( Supplementary Fig. 7 and Supplementary Movies 1-3 online) . Injection of fluorescent quantum dots into the dorsal aorta of morphant zebrafish to bypass the block at the level of the branchial arch arteries confirmed that these vessels formed a patent lumen ( Supplementary Fig. 7 and Supplementary Movies 4-6 online). These findings suggest that defects in endothelial tube formation observed in deficient endothelial cells do not arise because of loss of intracellular endothelial vacuole-like structures.
HEG1-CCM signaling regulates endothelial junctions in vivo
An ultrastructural characteristic of human CCMs is the presence of abnormal endothelial cell-cell junctions and gaps between endothelial cells [15] [16] [17] , and a recent study showed a role for KRIT1 in the dynamic regulation of endothelial cell-cell junctions in vitro 18 . Thus, one mechanism by which HEG1-CCM protein signaling might regulate cardiovascular development and integrity is through regulation of endothelial cell association. To directly assess the role of HEG1 in regulating endothelial junctions in vivo, we used transmission electron microscopy to examine cell-cell junctions in the endothelium of neonatal mouse lymphatic vessels. The dilated mesenteric lymphatic vessels of Heg1 -/-neonatal mice showed markedly shortened endothelial junctions compared to vessels in control littermates (mean length of junctions, 1,769 ± 506 nm for Heg1 -/-versus 3,355 ± 1,009 nm for Heg1 +/+ ; P ¼ 0.01; Fig. 5a ,b) and were accompanied by endothelial gaps not present in control collecting mesenteric lymphatic vessels (Fig. 5c) . Similarly shortened junctions were identified in the endocardium of ccm2-morphant zebrafish hearts (Supplementary Fig. 8 online) . Finally, analysis of the constricted, bloodless aortas of E9 CCM2-deficient mouse embryos also revealed shortened endothelial junctions despite the fact that the caliber of these vessels was markedly reduced (Supplementary Fig. 8 ). These findings indicate that defective endothelial junctions characterize both the dilated and constricted cardiovascular phenotypes of animals lacking HEG1-CCM protein signaling as well as human CCMs. Notably, the levels of b-catenin, VE-cadherin and claudin-5, key components of endothelial junctions, were preserved in the lymphatic vessels of HEG-1 deficient mice, in the hearts and vessels of zebrafish embryos lacking heg or ccm2 and in CCM2-deficient HUVECs ( Supplementary Fig. 9 online) . These findings suggest that HEG1-CCM protein signaling may regulate the function of these proteins rather than their expression.
HEG1 receptors couple to CCM proteins through KRIT1
Our findings suggest that HEG1 receptors interact with CCM proteins in an endothelial cell-autonomous signaling pathway: HEG1 is expressed in endothelial cells in zebrafish and mice; Heg1 -/-; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ mouse embryos and heg-and ccm2-morphant zebrafish embryos show aberrant vessel formation at an early developmental time point when vessels are composed exclusively © 2009 Nature America, Inc. All rights reserved. (c) The HEG1 intracellular tail interacted with KRIT1 and CCM2. HA-tagged mouse CCM2 and Myc-tagged mouse KRIT1 were expressed in HEK293T cells, and pull-down assays were done with affinity matrices containing the intracellular tail of either the human a 2b integrin or human HEG1. The HEG1 tail efficiently pulled down KRIT1 in the absence of CCM2, but not vice versa. The results shown are representative of 43 independent experiments. (d) HEG1 interacted with ccm2 through krit1. Flag-tagged zebrafish krit1, HA-tagged zebrafish ccm2 and HA-tagged zebrafish ccm2-L197R were expressed in HEK293T cells, and pull-down assays were done using human a 2b or human HEG1 intracellular tail affinity matrices as in c. ccm2-L197R did not associate with the HEG1 tail (far right lane). The results shown are representative of 43 independent experiments. (e) The HEG1 tail efficiently bound endogenous KRIT1. Pull-down assays using a 2b or HEG1 tail affinity matrices were done using lysates from CHO cells transfected with Flag-tagged human CCM2. Endogenous KRIT1 was detected with monoclonal antibody to KRIT1 (top) and heterologous CCM2 with monoclonal antibody to Flag (bottom). The far right lane shows immunoblotting of cell lysate equivalent to 5% of the input for the pull-down assays. The results shown are representative of 43 independent experiments. (f) HEG1-CCM protein signaling at endothelial cell junctions. HEG1 receptors couple to KRIT1 and CCM2 through HEG1 tail-KRIT1 and KRIT1-CCM2 interactions, respectively. KRIT1 also interacts with the junctional proteins VE-cadherin and b-catenin (b-cat) and CCM2 also interacts with CCM3. HEG1-CCM protein signaling is proposed to regulate junction formation and function. ECM, extracellular matrix; NPxY, NPXY amino acid sequences; PTB, phosphotyrosine binding domain. Fig. 10 online). To determine whether HEG1 can interact with intracellular CCM2, we coexpressed Flag-tagged, wild-type mouse HEG1 or mouse HEG1 lacking most of its intracellular tail (HEG1DC) with hemagglutinin-tagged mouse CCM2 in HEK293T cells and conducted coimmunoprecipitation experiments with antibodies to Flag and CCM2. CCM2 coimmunoprecipitated with full-length HEG1 using antibodies to Flag (to pull down HEG1) or CCM2 (Fig. 6a,b) . In contrast, although HEG1DC was expressed at the cell surface at levels similar to those of full-length HEG1 ( Supplementary Fig. 11 online) , CCM2 did not coprecipitate with HEG1DC (Fig. 6a,b) .
To further define how the HEG1 intracellular tail associates with CCM proteins, we used affinity matrices containing the intracellular tail of human HEG1 or of human a 2b integrin to pull down hemagglutinin-tagged mouse CCM2 and Myc-tagged mouse KRIT1 heterologously expressed in HEK293T cells. The intracellular tail of HEG1, but not that of a 2b integrin, efficiently pulled down KRIT1 and both KRIT1 and CCM2 when they were coexpressed (Fig. 6c) . However, only small amounts of CCM2 were pulled down when it was expressed alone (Fig. 6c) , indicating that KRIT1 markedly facilitates CCM2 interaction with the HEG1 intracellular tail.
To further assess the mechanism of CCM2 association with HEG1, we compared the ability of human HEG1 to interact with zebrafish krit1 coexpressed with wild-type zebrafish ccm2 or with ccm2-L197R, a ccm2 protein with an amino acid substitution in the phosphotyrosine binding domain that blocks its binding to krit1 (ref. 8) ; the corresponding mutant allele of CCM2 has been identified as a cause of human CCM 6 . Expression of wild-type ccm2 efficiently rescued the big-heart phenotype of ccm2-deficient zebrafish embryos, but expression of ccm2-L197R did not ( Supplementary Fig. 12 online) , indicating that this amino acid substitution leads to a loss of ccm2 function in zebrafish and humans. As observed with the mouse proteins, the HEG1 receptor tail efficiently pulled down both krit1 and wild-type ccm2 when they were coexpressed in HEK293T cells, but only krit1 was efficiently pulled down when ccm2-L197R was coexpressed (Fig. 6d) . Finally, HEG1 receptor tails also efficiently pulled down endogenous KRIT1 in CHO cells, despite the fact that the levels of endogenous KRIT1 were so low that they could not be detected in 5% of the input cell lysate by immunoblotting with the same antibody (Fig. 6e) . These findings support a model in which HEG1 receptors couple to CCM proteins primarily through interaction with KRIT1 at endothelial cell-cell junctions (Fig. 6f) .
DISCUSSION
Human genetic studies have revealed that CCM is caused by haploinsufficiency of KRIT1, CCM2 or PDCD10, and genetic studies in mice and zebrafish have implicated these proteins in cardiovascular development. How the loss of this signaling pathway leads to these diverse cardiovascular defects has not been clear. Our studies of the expression and function of HEG1 and CCM2 support a mechanism in which HEG1 receptor signaling through CCM proteins is required to regulate endothelial cell-cell association during formation of the cardiovascular system and for its integrity thereafter. We identified endothelial junction defects identical to those in human CCMs in the dilated hearts and vessels of zebrafish and mice deficient in HEG1 or CCM2, suggesting that CCM proteins regulate vertebrate cardiovascular development through control of endothelial cell association and that defects in this regulation leads to human CCM pathogenesis.
Several lines of evidence suggest that the vascular defects observed in zebrafish, mice and humans lacking HEG1 and CCM proteins reflect the loss of an endothelial cell signaling pathway. Although Ccm2 gene expression was relatively low and not vascular specific, Heg1 expression was detected specifically in vascular tissues and was restricted to endothelial cells at the stages at which deficient mouse and zebrafish embryos first develop cardiovascular defects. The vascular defects observed in E9 Heg1 -/-; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ mouse embryos and 48-h.p.f. morphant zebrafish embryos lacking Heg or Ccm2 arose before the appearance of other vascular cell types, such as pericytes or smooth muscle cells, in which HEG1 might indirectly regulate endothelial cell function. Consistent with these observations, mosaic analysis in zebrafish embryos has suggested that krit1 functions cell autonomously during cardiovascular development 24 . Finally, CCM2-knockdown endothelial cells were defective in the formation of lumenized tubes, and biochemical studies showed that HEG1 receptors coupled to CCM proteins such as CCM2 primarily through the KRIT1 protein. These findings strongly support a conserved cell-autonomous mechanism in which HEG1 receptors signal through CCM proteins to regulate endothelial cells during the formation and function of the heart and vessels.
Common ultrastructural defects in endothelial junctions suggest that the nonpatent branchial arch arteries that appear early in the development of mouse and zebrafish embryos lacking HEG1-CCM protein signaling, the diverse cardiovascular integrity defects in older HEG1-deficient mice, and the vascular defects in human CCMs can all be explained by varying degrees of loss of endothelial cell-cell association. In our studies, the most severe cardiovascular defects were observed in 48-h.p.f. morphant zebrafish embryos and E9 Heg1 -/-; Ccm2 lacZ/+ and Ccm2 lacZ/lacZ mouse embryos. In these animals, the differentiation and proliferation of early endothelial cells and their migration to sites of vessel formation (vessel patterning) were undisturbed (consistent with our observation that CCM2 deficient HUVECs migrated normally in vitro), but endothelial cell assembly into a lumenized, patent circulatory system was blocked. Recent studies in zebrafish suggest that patent vessels arise either through the coalescence of vacuoles in single endothelial cells 22 (that is, a mechanism within endothelial cells) or through the circumferential arrangement of endothelial cells that are connected by cell-cell junctions 21, 23 (a mechanism between endothelial cells). Our finding that endothelial cell vacuolization and lumenization were preserved in the ISVs of zebrafish embryos lacking the HEG1-CCM protein pathway is most consistent with a defect in endothelial cell-cell association.
The defects observed in the integrity of the heart, blood vessels and lymphatic vessels of HEG1-deficient mice also support the idea that impaired endothelial cell-cell association results from loss of HEG1-CCM protein signaling. The dilated, leaky lymphatic vessels of HEG1-deficient mice recapitulated many of the key structural and functional defects observed in human CCMs and heg-deficient zebrafish hearts, including shortened endothelial cell junctions, abnormal coverage of endothelial cells by adjacent cell types such as pericytes or cardiomyocytes, and vessel leakage and rupture. In addition, we observed dilated lymphatic vessels in Heg1 +/-; Ccm2 lacZ/+ mice but not in Heg1 +/-or Ccm2 lacZ/+ mice (data not shown), a result consistent with a genetic link between HEG1 and CCM2 in the formation of CCM-like dilated vessels and in early vessel formation in embryos. Finally, KRIT1 was recently found to localize at and functionally regulate endothelial cell junctions 18 , and we found that heterologously expressed HEG1 receptors similarly colocalized with b-catenin at endothelial junctions. Thus, a unifying mechanism to explain these diverse vascular phenotypes is one in which HEG1 signaling through CCM proteins is required for endothelial cells to associate with each other to create and maintain the vertebrate cardiovascular system.
A final question with important therapeutic implications is whether and how these studies advance our understanding of human CCM pathogenesis. Although molecular and genetic pathways are frequently postulated to link embryonic cardiovascular development and adult cardiovascular disease states, such links are often tenuous. It is therefore noteworthy that our studies of HEG1-CCM signaling in developing mice and zebrafish support conservation of the role of this pathway in both development and disease. Our findings suggest that the primary role of HEG1-CCM signaling is to control the association of endothelial cells to create and maintain cardiovascular structures. Thus, CCMs are predicted to be a disease of defective endothelial association, and agents that positively regulate endothelial junction formation might provide a means of stabilizing human CCMs or preventing their de novo formation. Alternatively, activation of HEG1-CCM signaling might provide a means of treating vascular diseases characterized by vascular leakage or defective vessel integrity, such as sepsis. Studies to define better the components and in vivo role of this signaling pathway may therefore identify new strategies for treating inherited and acquired vascular diseases.
METHODS
Mice. We generated SV/129 embryonic stem cells heterozygous for the Heg1 allele by deleting exon 1 using recombineering-based gene-targeting techniques, and we microinjected the stem cells into C57Bl/6 blastocysts. We intercrossed F 1 -generation Heg1 +/-mice (50% 129, 50% C57Bl/6) and conducted phenotypic analysis on Heg1 -/-and wild-type littermates. We generated Heg1 +/-mice on a 495% C57Bl/6 background by backcrossing for 5 generations. We generated Ccm2 lacZ/+ mice from 129P2 embryonic stem cells in which an IRES-bGeo cassette had been inserted into Ccm2 exon 6 using a retroviral gene trap (Bay Genomics clone RRG051; ref. 14). We obtained Tg(Tek-cre)12Flv and Gt(ROSA)26Sor transgenic mice from Jackson Research Laboratories. Unless otherwise specified, we maintained all mice on a mixed genetic background. The University of Pennsylvania Institutional Animal Care and Use Committee approved all animal protocols. Genotyping primer sequences are available in Supplementary Methods online.
In situ hybridization and immunostaining. Primer sequences used to generate Heg1 and Ccm2 in situ probes are available in Supplementary Methods. We carried out radioactive in situ hybridization, immunostaining and TUNEL staining on paraformaldehyde-fixed, paraffin-embedded sections. Detailed protocols are available at http://www.med.upenn.edu/mcrc/histology_core/. We used the following antibodies for immunostaining of tissue sections: rabbit monoclonal antibody to Ki67 (1:250; Vector Laboratories), mouse monoclonal antibody to a-smooth muscle actin (1:100; 1A4, Sigma), rabbit polyclonal antibody to LYVE1 (1:2,000; ref. 25) , mouse monoclonal antibody to b-catenin (1:100; BD Transduction), rat monoclonal antibody to Flk1 (1:50; PharMingen) and rabbit polyclonal antibody to claudin-5 (1:50; Zymed). We injected antisense morpholino oligonucleotides (Gene Tools) that interfere with the splicing of ccm2 and heg 11, 12 into the yolks of one-cell-stage embryos at a dose of 5 ng. To rescue the big-heart phenotype caused by the ccm2 morpholino, we first injected the one-cell-stage embryos with 5 ng of the ccm2 morpholino and then injected half of those embryos with 100 pg of cRNA encoding ccm2 or ccm2-L197R. We carried out microangiography of zebrafish embryos as described 29 . We injected red fluorescent (580 and 605 nm) 0.02-mm carboxylate-modified FluoSphere beads (Invitrogen) or 10 mg ml -1 70-kDa FITC-dextran (Sigma) into the sinus venosus of 48-h.p.f. zebrafish embryos. We mounted the embryos laterally in 2% methylcellulose and acquired images using an Olympus MVX10 microscope.
Immunoprecipitation and immunoblotting. We subcloned full-length mouse HEG1 without endogenous signal peptide (amino acids 38-1,313) and C-terminally truncated HEG1 (amino acids 38-1,207) into pcDNA3.1 with a human interleukin-1 signal peptide, an N-terminal Flag epitope and a Cterminal v5 epitope (see Supplementary Fig. 1b) . We cloned His 6 -recombinant human HEG1 intracellular tail containing an in vivo biotinylation peptide tag at the N terminus into pET15b as previously described for integrin intracellular-tail model proteins 30 . We expressed and purified tail proteins from Escherichia coli 31 .
For coimmunoprecipitation studies, we transfected plasmids driving expression of Flag-tagged full-length and truncated mouse HEG1 and hemagglutinintagged mouse CCM2 into HEK293T cells. After 48 h, we incubated the cells for 10 min in lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 25 mM EDTA, 1% NP-40, 0.5% sodium deoxycholate, PhosStop (Roche) and complete protease inhibitor (Roche), pH 8) drawn through a 25-gauge needle and cleared by centrifugation. We conducted Flag immunoprecipitation with 2 mg ml -1 antibody to Flag (M2, Sigma) and CCM2 immunoprecipitation with polyclonal antibody to CCM2 (2055, see Supplemental Methods) for 42 h and then incubated with protein G-agarose (Invitrogen) for 1 h. We detected proteins using the following antibodies: mouse monoclonal antibody to Flag (1:500; M2, Sigma), mouse monoclonal antibody to hemagglutinin (1:2,000; Abcam) and horseradish peroxidase-conjugated goat antibody to mouse IgG (1:5,000; Jackson ImmunoResearch).
For affinity matrix pull-down assays, we transfected HEK293T and CHO cells with plasmids driving expression of Myc-tagged mouse KRIT1, hemagglutinin-tagged mouse CCM2, Flag-tagged zebrafish krit1, hemagglutinintagged zebrafish ccm2, hemagglutinin-tagged zebrafish ccm2-L197R and Flag-tagged mouse CCM2. We incubated the cells for 10 min in lysis buffer (25 mM HEPES (pH 7.4), 100 mM NaCl, 0.5% NP-40 and complete protease inhibitor (Roche)). After clarification, we incubated 350 mg of lysate with 10 mg of immobilized human HEG1 tail overnight. We detected proteins using the following antibodies: mouse monoclonal antibody to Flag (1:2,000; M2, Sigma), mouse monoclonal antibody to Myc (1:2,000; Abcam), mouse monoclonal antibody to hemagglutinin (1:2,000; Abcam), polyclonal antibody to KRIT1 (1:1,000; 6832, ref. 18), horseradish peroxidase-conjugated goat antibody to mouse IgG (1:5,000; Jackson ImmunoResearch) and horseradish peroxidase-conjugated donkey antibody to rabbit IgG (1:5,000; Jackson ImmunoResearch). We carried out all steps at 4 1C.
Electron microscopy and cell-cell junction quantitation. We fixed neonatal mouse gut mesentery, 48-h.p.f. zebrafish embryos and E9.5 mouse embryos overnight, embedded them in Polybed 812 (Polysciences), sectioned them, stained them and examined them with a JEOL 1010 electron microscope fitted with a Hamamatsu digital camera. We imaged all identifiable endocardial cellcell junctions from six Heg1 +/+ and five Heg1 -/-lymphatic vessel cross-sections (66 and 123 junctions, respectively), and we quantitated junction lengths using ImageJ. We similarly imaged and quantitated endothelial cell-cell junctions from three control and four ccm2 morpholino-injected zebrafish atria crosssections (88 and 107 junctions, respectively) and four Ccm2 +/+ and six Ccm2 lacz/lacz mouse dorsal aorta cross-sections (128 and 107 junctions, respectively). We ordered the junctions by length and determined the mean junction length for each tercile. We also calculated the percentage of junctions o1,000 nm, 1,000-2,500 nm and 42,500 nm. Lastly, we calculated the overall mean junction length from the mean junction lengths for each heart or vessel cross-section.
Statistics. We calculated P values using an unpaired two-tailed Student t test or w 2 analysis as indicated.
Note: Supplementary information is available on the Nature Medicine website. 
